跳至主要内容
临床试验/IRCT2016050127520N2
IRCT2016050127520N2已完成未知

Effect of IVIg on Pregnancy Rate of Patient with recurrent pregnancy loss with Immunological Causes

Tabriz university of medica; sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 41 years(—)
性别
Female

入选标准

  • Patients who experienced at least three miscarriage; patients with Azeri origin; Patients who did not have any type of immunotherapy in his medical history.
  • Exclusion criteria: Patients below 18 years and above 41 years; Patients with abnormal karyotype or chromosomal disorders; patients who have bleeding problems; Patients who have chronic disorders such as diabetes; Patients who have HIV, HCV or HBV positive tests; Patients who have a history of asthma and allergies to certain drugs; patients who have uterus anomalies.

排除标准

  • 未提供

研究者

发起方
Tabriz university of medica; sciences

相似试验